FLUCATs - COVID vaccination

Metadata

Coding system
SNOMED CT (UK Clinical Edition)
Coding system release
36.4.0
Author
Fisher
Codelist ID
user/Louis/flucats-covid-vaccination
Version ID
56209fa0
Number of codes included
21

Actions

Download CSV Download definition Clone this codelist

Versions

  1. 56209fa0 Published
    Created: 16 Aug 2023 at 13:18

About

No metadata has been provided for this codelist.

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

code term
1119305005 Vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen
1119349007 Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid
1119350007 Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid
1144997007 Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid
1156257007 Administration of vaccine product against severe acute respiratory syndrome coronavirus 2
1157024006 Vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen
1157107003 Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
1157196000 Administration of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen
1162643001 Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen
1162645008 Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen
1179496000 Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen
1187593009 Vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein
1193583000 Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein
1324671000000103 Immunisation course to achieve immunity against severe acute respiratory syndrome coronavirus 2
1324681000000101 Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine
1324851000000106 Severe acute respiratory syndrome coronavirus 2 immunisation course started
28531000087107 Vaccine product against severe acute respiratory syndrome coronavirus 2
29061000087103 Vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
30141000087107 Vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen
840534001 Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen
90640007 Coronavirus vaccination

This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.

COVID-19 vacc

Included 18 out of 74 matching concepts.

Show matching concepts
  • Administration of fifth dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363831000000108)
  • Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (1324681000000101)
  • Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1144997007)
  • Administration of fourth dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363791000000101)
  • Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (1324691000000104)
  • Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157197009)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1144998002)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162646009)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (1179497009)
  • Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (1157108008)
  • Administration of third dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363861000000103)
  • Administration of vaccine product against severe acute respiratory syndrome coronavirus 2 (1156257007)
  • Administration of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157196000)
  • Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (1157107003)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (840534001)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (1193583000)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1119350007)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162645008)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (1179496000)
  • Adverse reaction to component of vaccine product against severe acute respiratory syndrome coronavirus 2 (1156256003)
  • Adverse reaction to component of vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1142180003)
  • Adverse reaction to component of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157195001)
  • Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (1157106007)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (1142182006)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1142181004)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162644007)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (1179495001)
  • Application for medical exemption from severe acute respiratory syndrome coronavirus 2 vaccination approved (1365751000000105)
  • Application for medical exemption from severe acute respiratory syndrome coronavirus 2 vaccination rejected (1365761000000108)
  • Inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (1157198004)
  • Inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (1157200005)
  • Second dose of inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (1157199007)
  • Second dose of inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (1157201009)
  • Second dose of severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (1145035007)
  • Second dose of severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (1145034006)
  • Second dose of severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (1157113007)
  • Second dose of severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (1157120000)
  • Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (1162648005)
  • Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (1162650002)
  • Second dose of severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccine contraindicated (1179499007)
  • Second dose of severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccine declined (1179501004)
  • Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (1145028004)
  • Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (1145026000)
  • Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (1145031003)
  • Severe acute respiratory syndrome coronavirus 2 antigen vaccination not indicated (1145030002)
  • Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (1145023008)
  • Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (1145033000)
  • Severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein vaccine contraindicated (1193584006)
  • Severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein vaccine declined (1193582005)
  • Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (1145029007)
  • Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (1145022003)
  • Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (1145032005)
  • Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (1157110005)
  • Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (1157118003)
  • Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (1162647000)
  • Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (1162649002)
  • Severe acute respiratory syndrome coronavirus 2 vaccination declined (1156270003)
  • Severe acute respiratory syndrome coronavirus 2 vaccination fifth dose declined (1363851000000101)
  • Severe acute respiratory syndrome coronavirus 2 vaccination first dose declined (1324741000000101)
  • Severe acute respiratory syndrome coronavirus 2 vaccination fourth dose declined (1363811000000100)
  • Severe acute respiratory syndrome coronavirus 2 vaccination not indicated (1156267002)
  • Severe acute respiratory syndrome coronavirus 2 vaccination second dose declined (1324751000000103)
  • Severe acute respiratory syndrome coronavirus 2 vaccination third dose declined (1363781000000103)
  • Severe acute respiratory syndrome coronavirus 2 vaccine contraindicated (1156265005)
  • Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccine contraindicated (1179498004)
  • Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccine declined (1179500003)
  • Vaccine product against severe acute respiratory syndrome coronavirus 2 (28531000087107)
  • Vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157024006)
  • Vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (29061000087103)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (1119305005)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (1187593009)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1119349007)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162643001)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (30141000087107)

coronavirus 2 immunisation

Included 1 out of 7 matching concepts.

Show matching concepts
  • Severe acute respiratory syndrome coronavirus 2 immunisation course abandoned (1324861000000109)
  • Severe acute respiratory syndrome coronavirus 2 immunisation course contraindicated (1324761000000100)
  • Severe acute respiratory syndrome coronavirus 2 immunisation course declined (1324811000000107)
  • Severe acute respiratory syndrome coronavirus 2 immunisation course done (1362611000000106)
  • Severe acute respiratory syndrome coronavirus 2 immunisation course not done (1324821000000101)
  • Severe acute respiratory syndrome coronavirus 2 immunisation course not indicated (1324731000000105)
  • Severe acute respiratory syndrome coronavirus 2 immunisation course started (1324851000000106)

coronavirus vaccination

Included 11 out of 24 matching concepts.

Show matching concepts
  • Administration of fifth dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363831000000108)
  • Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (1324681000000101)
  • Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1144997007)
  • Administration of fourth dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363791000000101)
  • Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (1324691000000104)
  • Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157197009)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1144998002)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162646009)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (1179497009)
  • Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (1157108008)
  • Administration of third dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363861000000103)
  • Administration of vaccine product against severe acute respiratory syndrome coronavirus 2 (1156257007)
  • Administration of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157196000)
  • Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (1157107003)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (840534001)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (1193583000)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1119350007)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162645008)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (1179496000)
  • Coronavirus vaccination (90640007)
  • Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (1145028004)
  • Severe acute respiratory syndrome coronavirus 2 antigen vaccination not indicated (1145030002)
  • Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (1145029007)
  • Severe acute respiratory syndrome coronavirus 2 vaccination not indicated (1156267002)

immunity against severe acute respiratory syndrome coronavirus 2

Included 1 out of 1 matching concepts.

Show matching concepts
  • Immunisation course to achieve immunity against severe acute respiratory syndrome coronavirus 2 (1324671000000103)